Digital Technologies for Better Pharma Tomorrow
Keywords:
digital therapeutics, digital medicine, app-based healthcare, and regulatory aspects.Abstract
The digitisation of healthcare has given patients greater influence than ever before. Digital health solutions are therefore now essential to meet the needs of more empowered patients who are taking an active role in their own treatment choices. A variety of platforms and systems that use technology to improve healthcare delivery are included in the field of digital health. Digital therapeutics (DTx) is a subset of digital health solutions that offers software-driven therapeutic treatments based on evidence for the management and prevention of illnesses. A thorough overview of DTx, including its uses and functions in healthcare and related regulatory aspects, is what this review seeks to present. Demonstrated how developments in online platforms, blockchain, and artificial intelligence are changing pharmacy services and education.
Downloads
References
1Lendrem D, Senn SJ, Lendrem BC, Isaacs JD. R&D productivity rides again?. Pharmaceutical Statistics. 2015 Jan;14(1):1-3.
https://doi.org/10.1002/pst.1653
Martin M. The dawn of digital therapeutics [monograph on the Internet] Platypus [Internet]. 2020 https://journals.lww.com/jfmpc/toc/2020/09050
Sepah SC, Jiang L, Peters AL. Long-term outcomes of a web-based diabetes prevention program: 2-year results of a single-arm longitudinal study. Journal of medical Internet research. 2015 Apr 10;17(4):e4052.
https://doi.org/10.2196/jmir.4052
Zovi A, Ferrara F, Gelmi M, Messina N, Pagani AA, Patti T, Zanetti Lorenzetti E, Torri T, Langella R. Digital therapeutics as a new weapon against diseases: focus on the current European legislation and possible therapeutic strategies. Expert Review of Medical Devices. 2025 Feb 1(just-accepted).
https://doi.org/10.2196/jmir.4052
Makin S. The emerging world of digital therapeutics. Nature. 2019 Sep 1;573(7775):S106-. https://doi.org/10.1038/d41573-020-00168-z
Makin S. The emerging world of digital therapeutics. Nature. 2019 Sep 1;573(7775):S106 https://wayf.springernature.com/?redirect_uri=https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs40290-022-00459-3
Gindi S, Methra T, Chandu BR, Boyina R, Dasari V. Antiurolithiatic and invitro anti-oxidant activity of leaves of Ageratum conyzoides in rat. World J. Pharm. Pharm. Sci. 2013 Feb 8;2:636-49.
https://assets.cureus.com/uploads/review_article/pdf/278191/20240912-296961-orr6fb.pdf
Kiranmai M, Renuka P, Brahmaiah B, Chandu BR. Vitamin D as a promising anticancer agent.
https://doi.org/10.12998/wjcc.v11.i7.1442
Nama S, Chandu BR, Awen BZ, Khagga M. Development and validation of a new RP-HPLC method for the determination of aprepitant in solid dosage forms. Tropical Journal of Pharmaceutical Research. 2011;10(4):491-7.
http://dx.doi.org/10.2174/2666958702101010032
Dara SR. An Overview of the Use of Natural Indicators in Acid-Base Titrations. UPI Journal of Pharmaceutical, Medical and Health Sciences. 2024 Jul 23:29-35.
https://doi.org/10.9734/jamps/2024/v26i6697
Dharmamoorthy G, Sabareesh M, Balaji A, Dharaniprasad P, Swetha T. An overview on top 10 pharma industry trends and innovations 2022. YMER Journal. 2022;21(11):2123-40.
Florence AT, Siepmann J. Dosage forms for personalized medicine: from the simple to the complex. InModern Pharmaceutics, Volume 2 2016 Apr 19 (pp. 511-530). CRC Press.https://doi.org/10.1016/j.addr.2003.10.008
Mathur S, Sutton J. Personalized medicine could transform healthcare. Biomedical reports. 2017 Jul 1;7(1):3-5.
https://doi.org/10.3892/br.2017.922
Yao R, Xu G, Mao SS, Yang HY, Sang XT, Sun W, Mao YL. Three-dimensional printing: review of application in medicine and hepatic surgery. Cancer biology & medicine. 2016 Dec 1;13(4):443-51.
https://doi.org/10.20892/j.issn.2095-3941.2016.0075
Trenfield SJ, Awad A, Goyanes A, Gaisford S, Basit AW. 3D printing pharmaceuticals: drug development to frontline care. Trends in pharmacological sciences. 2018 May 1;39(5):440-51.
https://doi.org/10.1016/j.tips.2018.02.006
Thakur A, Mishra AP, Panda B, Rodríguez DC, Gaurav I, Majhi B. Application of artificial intelligence in pharmaceutical and biomedical studies. Current pharmaceutical design. 2020 Aug 1;26(29):3569-78.
https://doi.org/10.2174/1381612826666200515131245
Thakur A, Mishra AP, Panda B, Rodríguez DC, Gaurav I, Majhi B. Application of artificial intelligence in pharmaceutical and biomedical studies. Current pharmaceutical design. 2020 Aug 1;26(29):3569-78.
https://doi.org/10.2174/1381612826666200515131245 .
Yoo JH, Jeong H, Chung TM. Cutting-edge technologies for digital therapeutics: a review and architecture proposals for future directions. Applied Sciences. 2023 Jun 8;13(12):6929.
https://doi.org/10.3390/app13126929
Cummins N, Schuller BW. Five crucial challenges in digital health. Frontiers in digital health. 2020 Dec 8;2:536203. https://doi.org/10.3389/fdgth.2020.536203
Prasanthi. G* Chandu Baburao Pradeep Kumar. Y Swarnalatha. D Gopinath. CHEMICAL PHARMACOLOGY OF KHAT LEAVES. Journal of Global Trends in Pharmaceutical Sciences. 2014, Vol. 5(4): 2024 – 2029.
https://www.jgtps.com/admin/uploads/mw7QGy.pdf
21. S Ganapaty,P Ramalingam, Ch Babu Rao; “Sar Study: Impact of hydrazide hydrazones and sulfonamide side chain on in vitro antimicrobial activity of quinoxaline”Int.J. Pharmacol.Biol 2 2 13-18 2008.
Published
How to Cite
Issue
Section
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright © Author(s) retain the copyright of this article.
.